G. Pandina

Ethical considerations in the conduct of rare disease neuroscience clinical trials

Approximately 7,000 rare diseases collectively affect an estimated 300 million people worldwide, yet fewer than 5 percent of these conditions have an approved therapy. Drug development for rare neurological and neurodevelopmental disorders presents unique ethical challenges that distinguish it from clinical research...

Lessons Learned from Drug Development Programs in Autism: Implications for Future Programs.